MHC-I-presented non-canonical antigens expand the cancer immunotherapy targets in acute myeloid leukemia

Yangyang Cai(Jilin University), Juan Xu(Harbin Medical University), Na Ding(The University of Texas MD Anderson Cancer Center), Jiaxin Yu(China Medical University), Yongsheng Li(Tongji Hospital), Donghao Li(Ministry of Education of the People's Republic of China), Yingying Ma(Northeast Agricultural University), Dezhong Lv(Harbin Medical University), Tiantongfei Jiang(Harbin Medical University)
Scientific Data
August 1, 2024
10.1038/s41597-024-03660-y
Cited by 15

Related Papers

Sequential Therapy with PARP and WEE1 Inhibitors Minimizes Toxicity while Maintaining Efficacy
|Cancer Cell|2019|243
The mRNA related ceRNA–ceRNA landscape and significance across 20 major cancer types
|Nucleic Acids Research|2015|209
Mechanism of the application of single-atom catalyst-activated PMS/PDS to the degradation of organic pollutants in water environment: A review
|Journal of Cleaner Production|2023|208
Huai Qi Huang corrects the balance of Th1/Th2 and Treg/Th17 in an ovalbumin-induced asthma mouse model
|Bioscience Reports|2017|71
Oral immunization of mice with a probiotic<i>Lactobacillus casei</i>constitutively expressing the α-toxoid induces protective immunity against<i>Clostridium perfringens</i>α-toxin
|Virulence|2019|61